Comment: MONARCH 3 trial: Abemaciclib for advanced breast cancer
Comment: MONARCH 3 trial: Abemaciclib for advanced breast cancer
CheckMate 214: nivolumab ipilimumab vs sunitinib for advanced or metastatic renal cell carcinoma
RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma
Chemotherapy then surgery no better than concomitant chemoradiation for advanced cervical cancer
MONARCH 3: Abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer
STORM trial to identify genetic variability in metastatic breast cancer
The UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer
STAMPEDE: Abiraterone acetate plus prednisolone or docetaxel
Problems with care: a patients perspective
Reduced work ability in cancer survivors
Problems with survivorship care in Europe
Underprovision and inequality of specialised cancer care